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ot bssue through the central articulation. Subsequent accumulation of nestn- 
timal tissue is uniformly distributed througho'Jt he slant. We conclude: Serial 
lntravascular ultrasound imaging shows that restenosis at the CA (compared 
to the edges or body) of Palmaz-Schatz sfants Is the result of a smaller Initial 
lumen (smaller sfant area and tissue prolapse) and not due to a prupensily 
for Ip.c~'eased neointimal tissue accumulation. 
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~ REsMnosla STent {REST) Study: Randomized ~ la l  
Comparing Slanting and Bal loon Angloplasty for  
~matment of  Restenosis After Balloon Angloplasty 
Ralmund Erbel, Michael Haude, Hans W. H0pp, Carlos Macaya, 
Maeakiyo Nobwoshi, Peter Pabst, Martin Sigmund, Haka~ Emanuetsson, 
Bah'el Heublein, Wolfgang Rutsch, Gunhlld Hero.ann, on behalf of the 
REST Study Group. Dept. of Cardiology, University Essen, Germany 
The REST-Study is a multicenfar randomized trial comparing the implantation 
of a single Palmaz-Schatz sfant vs. balloon a~gioplasty (PTCA) in i~tianls 
(pts) with restenosis in native coronary arteries, Pts enrelmem (n = 4Q0) 
was completed in May lg95. According to the protocol, an intenm analyeis 
acute and 6.month follow-up (FU) was performed on fhe first 123 pts. For 
quantitative coronary angiography, a CMS system (Medis, Netherlands) was 
used to assess p~'e, post Intervention and at 6 month FU minimal uminal 
diameter. 
S~emeeF[n - - ~r _PTGA {. - 87} 
Reference dismeter ( am) 3.01 d: 0.32 3.04.;- 0.26 
MLD {turn) p~-intervent!on 1.25:E 0.44 1.20 :t: 0.35 
MLD (am) post-intmvention 3.12:E 0.43 2.33 + 0.57 
MLD (am) at FU 2.14 ~ 0.66 1.86 ± 0.56 
Reslenosis with rein~'erve~tion 11.7"/. 37% 
Acute thrombosis I.L~', 1.2% 
Subacule thrombosis 3.5% - 
Emergency GABG - - 
Blee~ing "12.3% 4.6% 
Death - - 
The interim analysis of the REST-Sfudy demonstrates (1) favorable results 
concerning acule and FU angiographlc lumen diameter and (2) a reduced 
restenosis rate based on necessary reinterventions for atenting comPared to 
PTCA. 
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~ Stanting In Chronk: Coronary Occlusion (SICCO): A 
Multicenter, Randomized, Controlled Study 
Per A. Sirnes, Svsin Golf, Yngvar Myreng, Per Mo/Isfad, Per Albertsson, 
H6kan Emanueisson~ Magne Brakka, Arild Mangschau, Knut Endresen. 
John Kjekshus for the SICCO Study Group. Fairing Heart Clinic, Felting, 
No~way 
Angicplasty of chronic cerenaP/occlusions (CCO) carries a high recurreeo~ 
rata. We randomized 119 pts, (58 .t- 11 years) after initial successful re. 
canalizatiori of CCO (duratiOn >_ 2 weeks, median 18 weeks, 33% TIMI-1 
occlusions) to conventional PTCA or implantation of Palmaz-Schatz stoat. 
The target vessel was LAD in 39%, LCX in 11%, and RCA in 50',,,. C~ronmy 
angtograms at baseline (after PTCA) and at 6 months foll0w-up examination 
were analyzed quantitatively, 
Analysis of 91 pts. who had completed follow-up by Sap. 95 showed a 
res|e~~s!s {> 50%) rate of 73% in the PTCA group vs. 33% in the stent group 
(p = 0.0001). Reeoctuslon rate was 24% vs. 15% (p = 0.27). Angina class, 
minimal uminal diameter (MLD) and % diameter slenesis were s lgn i f l c~ 
Improved in the stant lOtS. Them was one atant delivery failure, Major evsnts 
(AMI, PTCA or ACB in occlusion territory) occurred in 14 pts. in the PTCA 
group and 8 lOtS, in the stem group. 
PTGA (n = 36) Stem (n = 4.3) 
baseline 6 months l~asellne 6 months 
Anglns class (CCS) 2.80 ~: 0.53 1,56 -4-1.1 2.72 + 0.50 0.67 :E 0.9~" 
MLD {mm) 2.15 ~: 0.~3 1.11 :E 0.78 2.~2 :E0.51 1.78 :E 0.9~ = 
Reference diameter 3.21 :~: 0.S3 3.34 + 0.59 3.14±eA5 3.29-*-0.61 
% Otametef slSno~, 33~: 12 67=1=24 ~:f i l3 46 ~:;~* 
('p < 0.ca vs. PTCA). Fo0ow-up wn be comp~ed by De~. 95, a,d fln= results w~| be 
p~a,~YreeL 
C,o,'~uS/on: F'dmary atenting of chronic cerona~ o~usions in,Droves the 
long term clinical and ~ outcome, 
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~ S i x  Month Clinical and Angiographle Fol low-Up of  
Slanting Without Anticoagulation: The Tlclopldlne 
Aspirln Slant Evaluation (TASTE) Study 
Jean-Me c t.~tanche, Eugene P. Mc Fadden, Eric Van ~aelle, 
Nicolas Danchtn, Gillas Grellier, Mertia~ Hereon, Chd~tophe Bauters, Michel 
E, Bertrand. University of Lille, France 
Stont Implantation without anticoagulation is now standard management in 
many countries, In a prospective multicemar French study, we have followed 
Patients with stont implantation, managed with tiClopidine 500 mg and aspirin 
200 mg daJ/y, without oral anticoagulat~on. We report he anglograph/c follow- 
up in the first 105 patients who underwent successful atent implantation (TIMI 
grade 3 flow after ster4Jng without in-t~ital complica~n) and who were  
treated by protocol (ticfopidine continued for at least 1 month). Indications 
for slanting were failed angioplaaty (n ,, 50), a suboptimal result (n = 41), or 
eleotively (n = 14). 
During the 6 months after etenting I desth, unrelated to stenting, occurred 
(leukaemla): 1 asymptomaftc Patient underwent bypass surgery (referring 
physici=~ preference). "l~clopidine r lated neotr0Penia occurred in 4 Patients 
(On day 30, 30, 60, 60): allergic reactions occurred in 4 patients (all before 
day 18): t diges~ve hemonfiage (at ! month) and one gasVttis {3 months) 
oCCurred. 
At angingraphic follow-up, restenosis (> 5(P/~, StenOsis) was present in 
38 atents (36%), including 3 occlusions (3.2=/o). Intresfant redilatati0n was 
pedormed in 19 (18%) patients; dilatstion at non-stented segments in 11 
(10.4=/=) patients. 
In a population with a do~mented high risk of clinical complications tartl- 
ing managed by antipfatefet therapy alone had an excellent clinical outcome. 
Further studies are required to determine the factors associated with resteno- 
eis in this population. 
Diastolic Dysfunction: Mechanisms and 
Potential Treatment 
Tuesday, March 26, 1996, 8:30 a.m.,-10:00 ~.m. 
Orange County Convention Center, Room 230C 
8:30  
~ Improvement  Diastol ic in Pat ients of  Dysf.ncUon 
W'dh Aort ic Stenosis by Nll~roglycedn 
Christian Matter, t~_;~-~r Ma~Enov, Giuseppe Vassalli, Ot'(o M. Hess. 
Cardio~g~, Unive~ity Hospita£ Zurich, Switzerland 
Background: Diastolic dysfu~ion has been rel~ed in the majodty of pa- 
tients with left ventdcutar (LV) pressure overload hy - ,~y .  Thus, the 
purpose o1 the present study was to evaluate the effect of nitroglycerin (NTG) 
on diastolic dysfunction in I~tients (pts) wi~ severe ao~c stenosis (AS), 
Pat/ants and Meffmds: A total of 20 pts (10 AS; 10 controls, C) were 
included in the present analysis. LV hlgh-fic~elity p~ssun~; and simultaneous 
LV volumes were deterntined at rest and after intracomna~ adrnirdst~,tion f
150 pg NTG in AS pts, 7110 AS pts had diastolic (LVEOP >_ 14 mmHg) and 
4/10 had systolic (EF < 57%} dysftmctton. 
ReButs: Ejeclion tra~on (57 ~ 59%; NS), LV end~stelic volume, relax- 
afon rata, ean'y and late peak filling rate, LV end-systol/c hamber stiffness 
well as the constant of muscle slimness (9 vs. 7; NS) remained unchanged 
after NTG. LV end~astotic pressure (LVEDP), LV peak systolic pressure 
(LVSP: 204 vs. 190; p < 0.05) and LV end.diastolic ~amber stillness (ED$) 
decreased after NTG: 
LVEDP EDS 
0 . 0 ~ ~  
0 .... o.00 
0 NTG 0 NTG 
. . . . .  upper ange of corm,~lity (n= I 0) 
Corc/L~/ons; Oias folio dyb-ft.qlction iS prese~ in9110 ~s  with severe AS arid 
is improved in 7/10 ~ NTG, whereas systolic function remains unchanged. 
Thus, NTG exerts a loene~l effect on o'~stoti¢ ttmc~y/t in LV I1y~y.  
This ,eH:~n~e is ~ ~e to a vc~xlilatory (unk~ading) rather, than a 
~ract ~ effect 
